Zeaxanthin Mitigates Hydroxychloroquine‐Induced Retinal Toxicity and Metabolic Reprogramming in ARPE‐19 Cells
Journal of Biochemical and Molecular Toxicology · 2026
DOI: 10.1002/jbt.71015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Münire Berna Asal Altıparmak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Pharmacy, University of Hacettepe, Ankara, Turkiye. Hauptthemen laut MEDLINE: Zeaxanthins, Hydroxychloroquine, Retinal Pigment Epithelium. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hacettepe University.
Abstract (Originalsprache)
Long‐term usage of the commonly used autoimmune disease drug hydroxychloroquine (HCQ) can result in retinal toxicity due to elevated lysosomal pH, mitochondrial damage, and oxidative stress. Zeaxanthin (ZEA), a carotenoid found mostly in the macula, is known for its antioxidant and cellular protective properties. The purpose of this study was to examine how ZEA would lessen the cytotoxicity, oxidative stress, mitochondrial dysfunction, and metabolic reprogramming driven by HCQ. ARPE‐19 cells were treated with HCQ (1 mM), ZEA (1–10 μM), or their combinations for 72 h. Cell viability (MTT), apoptosis/necrosis (Annexin V–7AAD), reactive oxygen species (DCFDA), mitochondrial membrane potential (TMRM), and lysosomal acidification (Acridine Orange staining) were analyzed. Additionally, LC–QTOF/MS‐based untargeted metabolomics analysis and pathway enrichment assessments were performed. HCQ treatment decreased cell viability to 23%, increased necrosis and ROS production, and led to mitochondrial hyperpolarization and lysosomal neutralization. Metabolomics analysis revealed a decrease in taurine, GABA, uric acid, and TCA intermediates, and an increase in palmitic acid and prostaglandin levels. Combination treatment with ZEA (10 μM) increased cell viability to 47%, reduced ROS and necrosis rates, and increased pantothenic acid, γ‐glutamyl cysteine, and citrate levels, supporting glutathione synthesis and phase II detoxification pathways. ZEA demonstrated a significant protective effect on HCQ‐induced oxidative, mitochondrial, and metabolic stress. These findings suggest that ZEA may be considered as a potential therapeutic agent against HCQ‐induced retinotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Faculty of Pharmacy, University of Hacettepe, Ankara, Turkiye.
- Department of Analytical Chemistry, Faculty of Pharmacy, University of Hacettepe, Ankara, Turkiye.
- Department of Medical Biochemistry, Graduate Institute of Health Sciences, İnönü University, Malatya, Türkiye.
- Department of Biochemistry, Faculty of Pharmacy, University of Lokman Hekim, Ankara, Turkiye.
ORCID-Profile: Tuba Tüylü Küçükkılınç
Förderung
- Hacettepe University
Zitieren
APA
Altıparmak, M. B. A., Yıldırım, E. M., Kaplan, O., Koç, E., Erikçi, A., Çelebier, M., Küçükkılınç, T. T., & Uçar, G. (2026). Zeaxanthin Mitigates Hydroxychloroquine‐Induced Retinal Toxicity and Metabolic Reprogramming in ARPE‐19 Cells. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.71015
Vancouver
Altıparmak MBA, Yıldırım EM, Kaplan O, Koç E, Erikçi A, Çelebier M, et al. Zeaxanthin Mitigates Hydroxychloroquine‐Induced Retinal Toxicity and Metabolic Reprogramming in ARPE‐19 Cells. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.71015
BibTeX
@article{Altparmak2026,
author = {Altıparmak, Münire Berna Asal and Yıldırım, Emine Merve and Kaplan, Ozan and Koç, Emine and Erikçi, Açelya and Çelebier, Mustafa and Küçükkılınç, Tuba Tüylü and Uçar, Gülberk},
title = {Zeaxanthin Mitigates Hydroxychloroquine‐Induced Retinal Toxicity and Metabolic Reprogramming in ARPE‐19 Cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
doi = {10.1002/jbt.71015}
}
EUVIMED